CA
NZ
UK
AU
IND
US
AbbVie (NYSE:ABBV), a global biopharmaceutical company, is trading modestly higher in Wednesday's session after the FDA granted two Breakthrough Therapy Designations for telisotuzumab adizutecan, known as Temab-A, an investigational antibody-drug conjugate targeting the c-Met protein. One designation covers Temab-A in combination with bevacizumab for …
Absci (NASDAQ:ABSI) shares are trading sharply lower in Wednesday's session, with no company-specific negative announcement behind the move. The decline instead appears tied to investor caution ahead of the company's first readout from its ABS-201 hair-loss trial, expected this quarter, alongside a broader selloff …
Alignment Healthcare (NASDAQ:ALHC) shares are trading higher in Wednesday's session after the company announced it will expand itsMedicareAdvantage plan into three new California counties and add two major health systems to its provider network, timed ahead of the Medicare Annual Enrollment Period that begins …
Alamar Biosciences (NASDAQ:ALMR) shares are extending a sharp pullback in Wednesday's session, continuing a decline that began after the company announced a new board member and a new general counsel and chief people officer. Neither disclosure has obviously functioned as a negative catalyst, and …
Bright Minds Biosciences (NASDAQ:DRUG), a clinical-stage biotechnology company developing selective serotonin receptor agonists for central nervous system disorders, is trading higher in Wednesday's session. No new company-specific news has emerged today, and the move appears to extend renewed investor attention following the company's confirmed …
Fresenius Medical Care (NYSE:FMS) shares are plunging in Wednesday's session after the company announced that Shervin Korangy will become Chief Executive Officer and Chair of the Management Board, effective October 12, succeeding Helen Giza. The Supervisory Board's statement did not give a specific reason …
Glaukos (NYSE:GKOS), an ophthalmic medical technology company, is trading sharply higher in Wednesday's session onVolumewell above average, with the move coming as the company confirmed its third-quarter results will arrive after market close on October 28. The confirmed date, paired with recent guidance strength, …
Johnson & Johnson (NYSE:JNJ) shares are trading higher in Wednesday's session, outperforming a softer broader market, as two brokerages raised their price targets ahead of the company's third-quarter report scheduled for October 13. One raised its target to $290 and another to $303, with …
Eli Lilly (NYSE:LLY) shares are trading sharply higher in Wednesday's session after the FDA expanded approval for Jaypirca to cover first-line treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma, broadening the drug's addressable patient population. The news prompted a brokerage to raise its …
Nautilus Biotechnology (NASDAQ:NAUT), a Seattle-based, development-stage life sciences company building the Nautilus Voyager platform, is climbing sharply in Wednesday's session, with buying interest picking up as investors revisit a peer-reviewed publication in Nature Methods that validated the company's core technology. The study marked the …
Please wait processing your request...